Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118 GBX | 0.00% | 0.00% | +8.76% |
May. 08 | TRADING UPDATES: ECO hails vaccine results; Plant Health sales down | AN |
Apr. 25 | EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling | AN |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 51.02 and 40.97 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.76% | 101M | C | ||
-11.83% | 79.26B | B+ | ||
+15.37% | 8.39B | B- | ||
+28.00% | 3.74B | B- | ||
-1.39% | 3.27B | B- | ||
+21.28% | 1.69B | - | ||
-3.25% | 1.56B | B | ||
-18.63% | 1.29B | C- | ||
-1.17% | 1.28B | - | ||
-6.77% | 1.14B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EAH Stock
- Ratings ECO Animal Health Group plc